Showing results (1341-1350 of 3,474) with videos related to

Sort By:
Pageof 348
Microbes and Infection|January 9, 2007
Role of GPI-anchored NCAM-120 in rabies virus infectionKozue Hotta, Yurie Motoi, Akiko Okutani, et al.
Atherosclerosis|November 28, 2006
Catheter-based adenovirus-mediated anti-monocyte chemoattractant gene therapy attenuates in-stent neointima formation in cynomolgus monkeysKaku Nakano, Kensuke Egashira, Kisho Ohtani, et al.
Atherosclerosis|May 8, 2007
Azelnidipine has anti-atherosclerotic effects independent of its blood pressure-lowering actions in monkeys and miceKaku Nakano, Kensuke Egashira, Kisho Ohtani, et al.
Diabetes Technology & Therapeutics|January 8, 2013
A multicenter, phase III evaluation of the efficacy and safety of a new fixed-dose pioglitazone/glimepiride combination tablet in Japanese patients with type 2 diabetesShinzo Hiroi, Kenkichi Sugiura, Kumi Matsuno, et al.
The Journal of Steroid Biochemistry and Molecular Biology|July 17, 2013
Effect of an investigational CYP17A1 inhibitor, orteronel (TAK-700), on estrogen- and corticoid-synthesis pathways in hypophysectomized female rats and on the serum estradiol levels in female cynomolgus monkeysMasuo Yamaoka, Takahito Hara, Hideo Araki, et al.
European Journal of Pharmacology|December 3, 2013
Effects of novel TRPA1 receptor agonist ASP7663 in models of drug-induced constipation and visceral painRyosuke Kojima, Katsura Nozawa, Hitoshi Doihara, et al.
Cell Stem Cell|December 17, 2013
Redefining the in vivo origin of metanephric nephron progenitors enables generation of complex kidney structures from pluripotent stem cellsAtsuhiro Taguchi, Yusuke Kaku, Tomoko Ohmori, et al.
Scientific Reports|July 5, 2017
PAX2 is dispensable for in vitro nephron formation from human induced pluripotent stem cellsYusuke Kaku, Atsuhiro Taguchi, Shunsuke Tanigawa, et al.
Transplant Infectious Disease : an Official Journal of the Transplantation Society|December 20, 2019
Hepatitis B virus reactivation in kidney transplant patients with resolved hepatitis B virus infection: Risk factors and the safety and efficacy of preemptive therapyTakanori Mei, Hiroshi Noguchi, Yu Hisadome, et al.
Transplantation Proceedings|December 23, 2018
Preformed C1q-binding Donor-specific Anti-HLA Antibodies and Graft Function After Kidney TransplantationY Okabe, H Noguchi, K Miyamoto, et al.
Pageof 348